Ken Garber. Show Affiliations »
Abstract
Mesh： See more » AnimalsAntineoplastic Agents/administration & dosageAntineoplastic Agents/pharmacologyCombined Modality TherapyDrug Delivery SystemsGene Expression Regulation, Neoplastic/drug effectsGene Expression Regulation, Neoplastic/geneticsGene SilencingGenetic Therapy/adverse effectsGenetic Therapy/methodsHumansNeoplasms/drug therapyNeoplasms/geneticsNeoplasms/therapyOncogenes/geneticsRNA, Antisense/metabolismRNA, Messenger/metabolismRNA, Neoplasm/metabolismRNA, Small Interfering/administration & dosageRNA, Small Interfering/metabolismRNA, Small Interfering/pharmacology
Substances： See more » Antineoplastic AgentsRNA, AntisenseRNA, MessengerRNA, NeoplasmRNA, Small Interfering
Year: 2003 PMID： 12671010 DOI： 10.1093/jnci/95.7.500
Source DB: PubMed Journal: J Natl Cancer Inst ISSN： 0027-8874 Impact factor: 13.506